MRBK(MRBK)
MRBK
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $138M | $152M |
| Low | $136M | $150M |
| High | $139M | $154M |
| EBITDA Avg | $24M | $26M |
| Low | $23M | $26M |
| High | $24M | $26M |
| EBIT Avg | $23M | $26M |
| Low | $23M | $26M |
| High | $24M | $26M |
| Net Income Avg | $22M | $29M |
| Low | $21M | $28M |
| High | $23M | $30M |
| EPS Avg | $1.95 | $2.52 |
| Low | $1.85 | $2.45 |
| High | $2.03 | $2.59 |
| Analysts (Rev / EPS) | 1 / 2 | 1 / 2 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $36M | $37M | $35M | $38M | $39M | $40M |
| Low | $36M | $37M | $35M | $38M | $39M | $39M |
| High | $36M | $37M | $35M | $38M | $39M | $40M |
| EBITDA Avg | $6M | $6M | $6M | $7M | $7M | $7M |
| Low | $6M | $6M | $6M | $6M | $7M | $7M |
| High | $6M | $6M | $6M | $7M | $7M | $7M |
| EBIT Avg | $6M | $6M | $6M | $6M | $7M | $7M |
| Low | $6M | $6M | $6M | $6M | $7M | $7M |
| High | $6M | $6M | $6M | $6M | $7M | $7M |
| Net Income Avg | $7M | $7M | $6M | $7M | $8M | $8M |
| Low | $7M | $7M | $6M | $7M | $8M | $8M |
| High | $7M | $8M | $6M | $8M | $8M | $8M |
| EPS Avg | $0.60 | $0.61 | $0.53 | $0.61 | $0.68 | $0.69 |
| Low | $0.60 | $0.61 | $0.53 | $0.61 | $0.68 | $0.69 |
| High | $0.61 | $0.62 | $0.53 | $0.62 | $0.68 | $0.70 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |